The symposium, themed Neuro-Cybernetics at Scale, draws inspiration from the recent advances in AI and machine learning, where scaling has unlocked unprecedented performance. We believe neuroscience may be approaching a similar inflection point. By convening researchers in experimental neuroscience, robotics, machine learning, control theory, and theoretical neuroscience, we aim to explore how ideas of scaling and feedback can shape the future of systems neuroscience.

The "Spatial Omics and AI: Bridging Discovery and Translational Medicine" symposium, is a free event which will explore the impact of Spatial Proteomics and AI in Translational Research and Life Sciences.

Keynote speakers include: 

- Prof. Emma Lundberg (Stanford University)
- Dr. Andrea J. Radtke (Leica Microsystems)
- Dr. Thierry Nordmann (Max Planck Institute)
- Dr. Giuseppe Diaferia (Champalimaud Foundation)

Lung Cancer Fight Club - 2nd Round
September 27, 2024

Lisbon/Portugal

Organising Committee: Joana Ip * Nuno Pimentel * Patrícia Winckler * Pedro Vaz * Rita Barata * Sofia Granadeiro * Susana Simões 

On behalf of the Lung Unit Team of the Champalimaud Clinical Centre, we would like to invite you to participate in our second Lung Cancer Meeting - "Lung Cancer Fight Club -2nd Round", which will take place in the Champalimaud Foundation Auditorium on 27th September 2024.

CRSy24 - The ‘Ecology’ of Cancer: Understanding and Targeting Cancer-Host Interactions

#CRSy24 #TheEcologyOfCancer aims to bring together a diverse range of researchers to explore fundamental aspects of cancer initiation and progression within the organism's broader context. A main focus of this symposium will be the multidimensional interplay of tumour cells with different components of the local microenvironment, including diverse subsets of immune cells, the vasculature, neurons and stromal cells.

Do you know all about Non-Melanoma Skin Cancer (NMSC)?

We are thrilled to announce that the registrations for the NMSC Symposium “Non-Melanoma Skin Cancer. What do we know?”, hosted by the Champalimaud Foundation on the 7th of June, are now open!

This event will be a fusion of clinical expertise and research advancements, bringing together experts and healthcare professionals to discuss the latest research findings and clinical developments in the diagnosis and treatment of Non-Melanoma Skin Cancer.

The symposium will be organised as a single-track scientific meeting and count with keynote & invited speakers, talks selected from abstracts and a poster session together with other networking and social activities. It will be held on the 11^th and 12^th of March, 2024 at the Main Auditorium of the Champalimaud Foundation in Lisbon, Portugal.

Malignant melanoma is a highly aggressive form of skin cancer that is on the rise. However, recent breakthrough research has introduced new targeted therapies and immunotherapies for melanoma treatment, transforming the approach to treating melanoma and offering hope to patients with limited alternatives.

Lung cancer is the leading cause of death from cancer worldwide conferring high morbidity, mortality and costs. In Portugal, the scenario is no different. According to the World Health Organisation (Globocan), in 2020, 5415 new cases of Lung Cancer were diagnosed in our country, being the 4th most frequently diagnosed tumour in both genders (the 2nd if breast and prostate neoplasms are excluded), with greater relevance in males. 

#CRSy23 #BrainBodyWorld23 aims to foster the discussion of how internal states, such as hunger, thirst, and emotion, are generated and regulated by the brain, and how they interact with the body and the external world to drive behaviour.